InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by JOHNSON JOHN, Chief Executive Officer. Insider active across 3 companies, notably Strongbridge Biopharma plc. Aggregated, 11 reports have been recorded. The latest transaction was filed on 8 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
015,000 shares0
Common Stock
SEC:0001867096-22-000090:0·
478,312 shares
Common Stock
SEC:0000899243-21-039749·
478,312 shares
Common Stock
SEC:0000899243-21-039749:0·
610,092 shares
Ordinary Shares
SEC:0001179110-21-009282·
610,092 shares
Ordinary Shares
SEC:0001179110-21-009282:0·
478,312 shares
Common Stock
SEC:0000899243-21-039341·
€595,991334,868 shares@ €1.779881.8% of flow
Ordinary Shares
SEC:0001179110-21-009224·
478,312 shares
Common Stock
SEC:0000899243-21-039341:0·
€595,991334,868 shares@ €1.779881.8% of flow
Ordinary Shares
SEC:0001179110-21-009224:0·
€132,25350,867 shares@ €2.6018.2% of flow
Ordinary Shares
SEC:0001179110-21-007439·
€132,25350,867 shares@ €2.6018.2% of flow
Ordinary Shares
SEC:0001179110-21-007439:0·
11 of 11 declarations
About JOHNSON JOHN
John Johnson is the Chief Executive Officer and Director of Strongbridge Biopharma plc and Xeris Biopharma Holdings, Inc. In these roles, he oversees the operations and strategy of the company. Johnson is recognized for his expertise in the biopharmaceutical sector and his commitment to developing innovative treatments. His leadership is essential in guiding the vision and growth initiatives of Strongbridge and Xeris. He collaborates with management teams to ensure project success and stakeholder satisfaction.
